SCHEMBL31153540

SCHEMBL31153540

CCOC(=O)c1nc2cc(Br)ccc2c(=O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PDE3B Q13370 2/20 0.49
PDE3A Q14432 2/20 0.49
HPGD P15428 5/20 0.45
KDM4E B2RXH2 4/20 0.45
GABRA1 P14867 1/20 0.45
GABRB1 P18505 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRB2 P47870 1/20 0.45
GAA P10253 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
MAPT P10636 2/20 0.45
ATM Q13315 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TBK1 Q9UHD2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165225 1.00 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2PDE3BPDE3AHPGD
SCHEMBL8197895 0.90 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2PDE3BPDE3AHPGD
SCHEMBL30208243 0.90 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2PDE3BPDE3AHPGD
SCHEMBL13343548 0.87 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HPGDKDM4EGABRA1
SCHEMBL160847 0.85 GABRA1 (0.46) ALDH1A1HPGDKDM4EGABRA1GABRB1
SCHEMBL13343558 0.85 TSHR (0.51) ALDH1A1SMN1; SMN2HPGDKDM4EGABRA1
SCHEMBL13343406 0.85 ALOX15 (0.51) ALDH1A1SMN1; SMN2PDE3BPDE3AHPGD
SCHEMBL166851 0.84 MMP13 (0.58) ALDH1A1HPGDKDM4EGAACYP1A2
SCHEMBL16792659 0.83 SIRT2 (0.50) ALDH1A1SMN1; SMN2PDE3BPDE3AHPGD
SCHEMBL13343425 0.82 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2HPGDKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698544-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2026-02-25 EP disclosed
WO-2024220946-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-10-24 WO disclosed